JunB expression is a common feature of CD30+ lymphomas and lymphomatoid papulosis
about
Targeting c-Jun and JunB proteins as potential anticancer cell therapyCell transformation by v-Rel reveals distinct roles of AP-1 family members in Rel/NF-kappaB oncogenesis.The heat shock protein-90 co-chaperone, Cyclophilin 40, promotes ALK-positive, anaplastic large cell lymphoma viability and its expression is regulated by the NPM-ALK oncoprotein.CD30 expression in high-risk acute myeloid leukemia and myelodysplastic syndromesLymphocyte deficiency limits Epstein-Barr virus latent membrane protein 1 induced chronic inflammation and carcinogenic pathology in vivoJun-regulated genes promote interaction of diffuse large B-cell lymphoma with the microenvironment.Regulation of murine hematopoietic stem cell quiescence by Dmtf1Histopathologic diagnosis of lymphomatous versus inflammatory erythroderma: a morphologic and phenotypic study on 47 skin biopsies.Common and distinct mechanisms of different redox-active carcinogens involved in the transformation of mouse JB6P+ cells.Constitutive control of AKT1 gene expression by JUNB/CJUN in ALK+ anaplastic large-cell lymphoma: a novel crosstalk mechanism.Need for an improved molecular/genetic classification for CD30+ lymphomas involving the skin.Recent insights into the biology of Hodgkin lymphoma: unraveling the mysteries of the Reed-Sternberg cell.CD30-positive peripheral T-cell lymphomas share molecular and phenotypic features.Diagnostic and predictive biomarkers for lymphoma diagnosis and treatment in the era of precision medicine.Expression patterns of the activator protein-1 (AP-1) family members in lymphoid neoplasms.Cleavage of the JunB transcription factor by caspases generates a carboxyl-terminal fragment that inhibits activator protein-1 transcriptional activity.GSK3-SCF(FBXW7) targets JunB for degradation in G2 to preserve chromatid cohesion before anaphase.NPM-ALK and the JunB transcription factor regulate the expression of cytotoxic molecules in ALK-positive, anaplastic large cell lymphoma.Ets-1 activates overexpression of JunB and CD30 in Hodgkin's lymphoma and anaplastic large-cell lymphoma.NPM-ALK: The Prototypic Member of a Family of Oncogenic Fusion Tyrosine Kinases.CD30+ lymphoproliferative disordersImmunohistological analysis of the jun family and the signal transducers and activators of transcription in thymus.The AP-1 transcription factor JunB is essential for multiple myeloma cell proliferation and drug resistance in the bone marrow microenvironment.The Role of Activator Protein-1 (AP-1) Family Members in CD30-Positive Lymphomas.The expression levels of JunB, JunD and p-c-Jun are positively correlated with tumor cell proliferation in diffuse large B-cell lymphomas.Loss of stromal JUNB does not affect tumor growth and angiogenesis.The oncogenic JUNB/CD30 axis contributes to cell cycle deregulation in ALK+ anaplastic large cell lymphoma.The c-Jun and JunB transcription factors facilitate the transit of classical Hodgkin lymphoma tumour cells through G
P2860
Q28238777-876486E3-7B75-41AF-BE51-15E55234C0FFQ34101480-3662A567-B271-4142-AFF2-4ECC67695D88Q34297784-C47903FF-59F3-4EB4-BDD7-5A336E8906F7Q34300698-A354BFB9-2EE8-48C2-B034-C768D3639D40Q34586289-CA0135C2-E4E9-49D5-9A03-ECF061F638BFQ35056305-2EA5C6EB-7B22-4C87-89FC-23CDCCB8EB14Q35623644-D5081633-B7BC-4AC6-8B84-C6E04676C838Q35816893-DC865473-95BB-49C7-9DEA-F2964B0B0F3CQ36104372-BB1F7BCC-5FCC-42AC-A610-405E8AF7DEEDQ36248978-2D95F5F7-6381-48E7-8A14-ABFBA1C0078EQ36771224-F6257E83-4DFD-4975-958E-1EC007DF271EQ37004635-1056B3EC-1B92-4BA7-A11B-4BF557F11F8BQ37060660-B12DB8F9-2B56-471B-B908-753EBD01A4DCQ38882112-C09CB732-0489-4E7A-8A9B-6AFD52FD1034Q38947647-AD21FBA4-2AF0-4A13-B711-DB7D7051CB9FQ39141909-0EB6E0A1-D199-415A-9407-9F63BD7208ADQ39329020-6FF144EF-511F-4A8E-B2E5-611A622AC26BQ39590992-3840E4B8-7BE6-4035-A70A-CE4A6CA7F8F3Q40594788-818C5ADE-FA6B-4523-B3B0-E702A3630F9DQ42254184-F6E27A98-F392-42B1-B0BC-C7C82BE35A4BQ42415931-04B97613-42E8-4342-8B47-DDD948C6F868Q42653128-E0FE4F7E-F0E0-4BE5-8D3A-6353B61F044AQ51041591-145196A9-4B0D-4FCC-B729-C9D36DE13E92Q52337767-4F075F8F-1375-400A-819D-C46820266426Q52955946-B894B0F0-73C4-4E0C-B227-981CE4F22CC2Q53090556-7CD8ACB9-41FC-4FBD-8620-E703C57B06D9Q54327994-183F6DD5-2085-4E7C-911C-95FCF5C64E4FQ58099160-3D242CDA-5832-4BD8-B07E-2EFAC7AD319A
P2860
JunB expression is a common feature of CD30+ lymphomas and lymphomatoid papulosis
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
JunB expression is a common feature of CD30+ lymphomas and lymphomatoid papulosis
@en
JunB expression is a common feature of CD30+ lymphomas and lymphomatoid papulosis
@nl
type
label
JunB expression is a common feature of CD30+ lymphomas and lymphomatoid papulosis
@en
JunB expression is a common feature of CD30+ lymphomas and lymphomatoid papulosis
@nl
prefLabel
JunB expression is a common feature of CD30+ lymphomas and lymphomatoid papulosis
@en
JunB expression is a common feature of CD30+ lymphomas and lymphomatoid papulosis
@nl
P2093
P2860
P1433
P1476
JunB expression is a common feature of CD30+ lymphomas and lymphomatoid papulosis
@en
P2093
Athanasios Thomaides
Coralyn Atwell
Francois-Xavier Claret
George Z Rassidakis
L Jeffrey Medeiros
Richard Ford
P2860
P2888
P304
P356
10.1038/MODPATHOL.3800419
P577
2005-10-01T00:00:00Z
P5875
P6179
1037788058